Helen He

A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts

S. Tirrell, J. Brownell, M. Theisen, 2016, Journal of biomarkers.

LBY135, a novel anti‐DR5 agonistic antibody induces tumor cell–specific cytotoxic activity in human colon tumor cell lines and xenografts

Q. Deveraux, Youzhen Wang, C. Kowal, 2008 .

A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3).

M. Borad, J. Furuse, J. Bridgewater, 2020 .

Anti-tumor activity of TAK-659, a dual inhibitor of SYK and FLT-3 kinases, in AML models.

S. Tirrell, Jie Yu, M. Theisen, 2016 .

A phase II study of futibatinib (TAS-120) in patients (pts) with advanced (adv) solid tumors harboring fibroblast growth factor receptor (FGFR) genomic aberrations.

A. Hollebecque, T. Doi, K. Shitara, 2020 .